{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:04:58Z","timestamp":1777349098483,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijantimicag.2020.106021","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T17:04:07Z","timestamp":1589821447000},"page":"106021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA)-osteomyelitis"],"prefix":"10.1016","volume":"56","author":[{"given":"Vanessa","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Sofia","family":"Ant\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justina","family":"Prada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-4560","authenticated-orcid":false,"given":"Isabel","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Maltez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 E.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Capelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Igrejas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Poeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106021_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/S1984-82502013000100003","article-title":"Osteomyelitis: An overview of antimicrobial therapy","volume":"49","author":"Gomes","year":"2013","journal-title":"Brazilian J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cden.2016.12.001","article-title":"Microbiology of acute and chronic osteomyelitis and antibiotic treatment","volume":"61","author":"Dym","year":"2017","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/biom.22905","article-title":"Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions","volume":"2","author":"Ribeiro","year":"2012","journal-title":"Biomatter"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.actbio.2019.01.015","article-title":"Implantable antimicrobial biomaterials for local drug delivery in bone infection models","volume":"93","author":"Caplin","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tvjl.2019.06.003","article-title":"Bacterial osteomyelitis in veterinary orthopaedics: Pathophysiology, clinical presentation and advances in treatment across multiple species","volume":"250","author":"Gieling","year":"2019","journal-title":"Vet J"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00084-17","article-title":"Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions","volume":"31","author":"Kavanagh","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0007","first-page":"6","article-title":"Using genomics to understand meticillin- and vancomycin-resistant Staphylococcus aureus infections","author":"Giulieri","year":"2020","journal-title":"Microb Genomics"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0008","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/1120009X.2017.1404277","article-title":"The role of dalbavancin in the multi-disciplinary management of wound infections in orthopaedic surgery","volume":"30","author":"Arena","year":"2018","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0009","first-page":"7","article-title":"Potential savings through single-dose intravenous dalbavancin in long-term MRSA infection treatment - a health economic analysis using German DRG data","author":"Wilke","year":"2019","journal-title":"GMS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12011-016-0662-y","article-title":"The efficacy of boric acid used to treat experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus: an in vivo study","volume":"173","author":"G\u00fczel","year":"2016","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0011","doi-asserted-by":"crossref","first-page":"e986","DOI":"10.3928\/01477447-20130724-11","article-title":"Local application of free antibiotic powder in the treatment of osteomyelitis in a rat model","volume":"36","author":"Garcia","year":"2013","journal-title":"Orthopedics"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0012","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.diagmicrobio.2012.11.024","article-title":"Update of dalbavancin spectrum and potency in the USA: Report from the SENTRY Antimicrobial Surveillance Program (2011)","volume":"75","author":"Jones","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0013","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1128\/AAC.01453-08","article-title":"Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates","volume":"53","author":"Biedenbach","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/dki006","article-title":"Pharmacokinetics and excretion of dalbavancin in the rat","volume":"55","author":"Cavaleri","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/jac\/dkv357","article-title":"Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis","volume":"71","author":"Barnea","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0016","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.injury.2019.08.017","article-title":"A new small animal model for simulating a two-stage-revision procedure in implant-related methicillin-resistant Staphylococcus aureus bone infection","volume":"50","author":"Brunotte","year":"2019","journal-title":"Injury"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0017","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12891-016-1005-z","article-title":"A new model of implant-related osteomyelitis in the metaphysis of rat tibiae","volume":"17","author":"Harrasser","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0018","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/jsre.1998.5416","article-title":"Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms","volume":"79","author":"Gracia","year":"1998","journal-title":"J Surg Res"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1289157","article-title":"In vitro and in vivo biofilm characterization of methicillin-resistant Staphylococcus aureus from patients associated with pharyngitis infection","volume":"2016","author":"Gowrishankar","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jgar.2019.05.017","article-title":"First report of linezolid-resistant cfr-positive methicillin-resistant Staphylococcus aureus in humans in Portugal","volume":"17","author":"Silva","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0021","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2106\/00004623-198567080-00015","article-title":"The influence of skeletal implants on incidence of infection. Experiments in a canine model","volume":"67","author":"Petty","year":"1985","journal-title":"J Bone Jt Surg"},{"key":"10.1016\/j.ijantimicag.2020.106021_bib0022","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41598-018-28006-8","article-title":"Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model","volume":"8","author":"Kussmann","year":"2018","journal-title":"Sci Rep"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920301849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920301849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:32:50Z","timestamp":1735673570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920301849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0924857920301849"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106021","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA)-osteomyelitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106021"}}